16.25
+0.79(+5.11%)
Currency In USD
Address
9201 West Broadway Avenue
Minneapolis, MN 55445
United States of America
Phone
763 416 2840
Website
Sector
Healthcare
Industry
Medical - Devices
Employees
200
First IPO Date
June 30, 2021
| Name | Title | Pay | Year Born |
| Mr. Kevin Hykes | President, Chief Executive Officer & Director | 37,057 | 1966 |
| Mr. Jared Oasheim | Chief Financial Officer | 576,724 | 1983 |
| Mr. Paul Verrastro | Chief Marketing & Strategy Officer | 598,972 | 1963 |
| Ms. Tonya A. Austin SPHR | Chief Human Resources Officer | 0 | 1972 |
| Mr. Paul Pignato | Vice President of Research, Development and Operations | 0 | N/A |
| Dr. Philip B. Adamson M.D., M.Sc. | Chief Medical Officer | 0 | N/A |
| Mr. Robert Allen John | Chief Revenue Officer | 0 | N/A |
| Ms. Jonelle R. Burnham | Vice President & General Counsel | 0 | 1971 |
| Ms. Jennifer E. Englund | Senior Vice President of Global Clinical Affairs | 0 | N/A |
| Ms. Bonnie Handke M.B.A., R.N. | Senior Vice President of Patient Access, Reimbursement, & Healthcare Economics | 0 | N/A |
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The company sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, rest of Europe, and internationally. CVRx, Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.